Prophylactic treatment with growth hormone improves intestinal barrier function and alleviates bacterial translocation in stressed rats

Chinese Medical Journal

Volumn 117, Issue 2, 2004, Pages 264-269

  Ding, Lian An ^a   Li, Jie Shou ^b   Li, You Sheng ^b   Liu, Fang Nan ^b   Tan, Li ^b  

^a University Medical College   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Bacterial translocation; Growth hormone; Intestinal barrier; Lactulose mannitol test; Stress damage

Indexed keywords

CARBOHYDRATE; CD3 ANTIGEN; GROWTH HORMONE; IMMUNOGLOBULIN A; NITRIC OXIDE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTOXEMIA; FEEDING; HELPER CELL; INTESTINE MUCOSA PERMEABILITY; LYMPHOCYTE COUNT; MALE; NONHUMAN; PROSPECTIVE STUDY; RANDOMIZATION; RAT; RAT STRAIN; SEPSIS; SMALL INTESTINE MUCOSA; STATISTICAL ANALYSIS; STRESS; SUPPRESSOR CELL; TOTAL PARENTERAL NUTRITION;

ANIMALS; BACTERIAL TRANSLOCATION; GROWTH HORMONE; INTESTINAL MUCOSA; PARENTERAL NUTRITION, TOTAL; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STRESS;

EID: 1542476768     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Swank GM, Deitch EA. Role of the gut in organ failure: bacterial translocation and permeability changes. World J Surg 1996;20:411-417.
2. Wilmore DW, Smith RJ, O'Dwyer ST, et al. The gut: A central organ after surgical stress. Surgery 1988;104:917-923.
3. Eizaguirre I, Aldazabal P, Barrena MJ, et al. Effect of growth hormone on bacterial translocation in experimental short-bowel syndrome. Pediatr Surg Int 1999;15:160-163.
4. Zhou X, Li YX, Li N, et al. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: Animal experiment. World J Gastroenterol 2001;7:66-73.
5. Whiteland JL, Nicholls SM, Shimeld C, et al. Immunohistochemical detection of T-cell subsets and other leucocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem 1995;43:313-320.
6. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [18-N]-nitrate in biological fluids. Ann Biochem 1982;126:131-136.
7. Huang KF, Chung DH, Herndon DA. Insulinlike growth factor 1 ( IGF-1 ) reduces gut atrophy and bacterial translocation after severe burn injury. Arch Surg 1993;128: 47-54.
8. MacFie J, O'Boyle, Mitchell C, et al. Gut origin of sepsis: A prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999;45:223-228.
9. Fukushima R, Saito H, Inoue T, et al. Prophylactic treatment with growth hormone and insulin-like growth factor 1 improve systemic bacterial clearance and survival in a murine model of burn-induced gut-derived sepsis. Burns 1999;25: 425-430.
10. Ziegler TR, Leader LM, Jonas CR, et al. Adjunctive therapies in nutritional support. Nutrition 1997; 13 (9 Suppl) :64-72.
11. Tritos NA, Mantzoros CS. Recombinant human growth hormone: old and novel uses. Am J Med 1998;105:44-57.
12. Inoue Y, Copeland EM, Souba WW. Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg 1994;219:715-724.
13. Scopa CD, Koureleas S, Tsamandas AC, et al. Beneficial effects of growth hormone and insulin-like growth factor 1 on intestinal bacterial translocation, endotoxemia, and apoptosis in experimentally jaundiced rats. J Am Coll Surge 2000;190: 423-431.
14. Chen K, Nezu R, Inoue M, et al. Beneficial effects of growth hormone combined with parenteral nutrition in the management of inflammatory bowel disease: An experimental study. Surgery 1997;121:212-218.
15. MacFie J. Enteral versus parenteral nutrition: The significance of bacterial translocation and gut-barrier function. Nutrition 2000;16:606-611.
16. Carroll PV, Van den Berghe G. Safety aspects of pharmacological GH therapy in adults. Growth Horm IGF Res 2001;11:166-172.
17. Wilmore DW. The use of growth hormone in severely ill patients. Adv Surg 1999;33:261-274.
18. Van Deventer SJ, Ten Cate JW, Tytgat GN. Intestinal endotoxemia: Clinical significance. Gastroenterology 1988; 94:825-831.
19. O'Dwyer ST, Michie HR, Ziegler TR, et al. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 1988;123:1459-1464.
20. Qin HL, Su ZD, Hu LG, et al. Effect of early intrajejunal nutrition on pancreatic pathological features and gut barrier function in dogs with acute pancreatitis. Clin Nutr 2002;21: 469-473.
21. Mosenthal AC, Xu D, Deitch EA. Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber. Crit Care Med 2002;30:396-402.
22. Pscheidl E, Schywalsky M, Tschaikowsky K, et al. Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000;28:1489-1496.
23. Takagi K, Yamamori H, Toyoda Y, et al. Modulating effects of the feeding route on stress response and endotoxin translocation in severely stressed patients receiving thoracic esophagectomy. Nutrition 2000;6:355-360.
24. Mishima S, Xu DZ, Deitch EA. Increase in endotoxin-induced mucosal permeability is related to increased nitric oxide synthase activity using the Ussing chamber. Crit Care Med 1999;27:880-886.
25. Forsythe RM, Xu DZ, Lu Q, et al. Lipolysaccharide-induced enterocyte-derived nitric oxide induces intestinal monolayer permeability in an autocrine fashion. Shock 2002;17:180-184.